IP Library Granted Patent US 8,958,871
Granted Patent B2
US 8,958,871 · App. 13/007,370 · Granted Feb 17, 2015

Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach

Inventors: Denise Demarais (Saratoga, CA); Benjamin J. Clark (Redwood City, CA); Nicolas Zadno (Fremont, CA); Erik Thai (San Jose, CA); Hanson Gifford, III (Woodside, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/05A61N1/321A61N1/327A61N1/0551A61N1/36007A61N1/0514
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,958,871
App. No.
13/007,370
Granted
Feb 17, 2015
Kind
B2
Abstract

Methods and apparatus are provided for pulsed electric field neuromodulation via an intra-to-extravascular approach, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation and other conditions in target neural fibers. In some embodiments, the ITEV PEF system comprises an intravascular catheter having one or more electrodes configured for intra-to-extravascular placement across a wall of patient's vessel into proximity with target neural fibers. With the electrode(s) passing from an intravascular position to an extravascular position prior to delivery of the PEF, a magnitude of applied voltage or energy delivered via the electrode(s) and necessary to achieve desired neuromodulation may be reduced relative to an intravascular PEF system having one or more electrodes positioned solely intravascularly. The methods and apparatus of the present invention may, for example, be used to modulate one or more target neural fibers that contribute to renal function.

Claims (17)

1. A method for pulsed electric field neuromodulation via an intra-to-extravascular approach, the method comprising:

intravascularly advancing an electrode to a treatment site within vasculature of a human patient;

passing a portion of the electrode through at least a portion of a wall of the vasculature to position the electrode at an extravascular location via an intra-to-extravascular approach; and

extravascularly delivering a pulsed electric field via the electrode to induce neuromodulation.

2. The method of claim 1 , wherein intravascularly advancing an electrode to a treatment site within vasculature of a human patient further comprises intravascularly moving the electrode to a treatment site within a renal artery of the patient.

3. The method of claim 1 , wherein intravascularly advancing an electrode to a treatment site within vasculature of a human patient further comprises intravascularly moving an intravascular catheter having the electrode to the treatment site within the vasculature of the patient.

4. The method of claim 3 , wherein passing a portion of the electrode through at least a portion of a wall of the vasculature to positioning the electrode at an extravascular location via an intra-to-extravascular approach further comprises expanding an expandable element of the catheter.

5. The method of claim 1 , wherein intravascularly advancing an electrode to a treatment site within vasculature of a human patient further comprises moving the electrode through an intravascular catheter positioned at the treatment site.

6. The method of claim 1 , wherein extravascularly delivering a pulsed electric field to induce neuromodulation further comprises extravascularly applying the pulsed electric field to modulate a neural fiber that contributes to renal function.

7. The method of claim 6 , wherein modulating a neural fiber that contributes to renal function further comprises inducing, in the neural fiber, an effect chosen from the group consisting of irreversible electroporation, electrofusion, necrosis, apoptosis, gene expression alteration, cytokine upregulation alteration, and combinations thereof.

8. The method of claim 1 wherein passing a portion of the electrode through at least a portion of a wall of the vasculature to position the electrode at an extravascular location via an intra-to-extravascular approach further comprises piercing the wall of the vasculature, and advancing the electrode through the wall piercing.

9. The method of claim 8 , wherein piercing the wall of the vasculature further comprises forcing the electrode through the wall of the vasculature.

10. The method of claim 1 , wherein intravascularly advancing an electrode to a treatment site further comprises advancing at least one bipolar electrode pair to the treatment site.

11. The method of claim 10 , wherein passing a portion of the electrode through at least a portion of a wall of the vasculature to position the electrode at an extravascular location via an intra-to-extravascular approach further comprises moving the bipolar electrode pair extravascularly, and wherein extravascularly delivering a pulsed electric field further comprises extravascularly delivering the pulsed electric field across the bipolar electrode pair.

12. The method of claim 10 , wherein passing a portion of the electrode through at least a portion of a wall of the vasculature to position the electrode at an extravascular location via an intra-to-extravascular approach further comprises positioning a first electrode of the bipolar electrode pair at the extravascular location and positioning a second electrode of the bipolar electrode pair at an intravascular location.

13. The method of claim 1 further comprising infusing an agent to enhance the neuromodulation.

14. The method of claim 1 further comprising infusing an agent to protect non-target tissue.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2013
From: DEMARAIS, DENISE; CLARK, BENJAMIN J.; ZADNO, NICOLAS; THAI, ERIK; GIFFORD, HANSON, III
To: ARDIAN, INC.
Reel/Frame 031567/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 031568/0145 →
CHANGE OF NAME Recorded Nov 8, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 031608/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 030531/0717 →
CHANGE OF NAME Recorded Jun 3, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 030531/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2011
From: DEMARAIS, DENISE; CLARK, BENJAMIN J.; ZADNO, NICOLAS; THAI, ERIK; GIFFORD, HANSON, III
To: ARDIAN, INC.
Reel/Frame 025658/0347 →
Continuity (13)
Continuation 12616708 · Nov 11, 2009
Continuation 11363867 · Feb 27, 2006
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Provisional Application 60813589 · Dec 29, 2005
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Related Publication 20110202098A1 · Aug 18, 2011